GlassScriptPhysician profile
Julia Michelle White
NPI 1912369109
$1,296.05
in general payments reported to CMS, 2019-2025
15 companies · $336 in 2025
The $336 reported for 2025 was less than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $116 · 2021: $124 · 2022: $113 · 2023: $191 · 2024: $292 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $291.27 | 2023-2025 | Durysta |
| Alcon Vision LLC | $221.98 | 2023-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Omeros Corporation | $125.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $124.08 | 2021 | |
| Biotissue Holdings INC. | $115.78 | 2020 | |
| Allergan, INC. | $95.00 | 2022 | |
| Bausch & Lomb Americas INC. | $74.02 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $64.09 | 2024-2025 | |
| Harrow Eye, LLC | $51.45 | 2025 | Vevye |
| Thea Pharma INC. | $45.35 | 2024-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $26.81 | 2024 | Tyrvaya |
| Amgen INC. | $19.47 | 2025 | Tepezza |
| Novartis Pharmaceuticals Corporation | $17.92 | 2022 | |
| Sight Sciences, INC. | $13.18 | 2024 | Omni Surgical System |
| New World Medical,INC. | $10.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.